Advertisement
U.S. markets closed
Advertisement

ResMed Inc. (RMD)

NYSE - NYSE Delayed Price. Currency in USD
159.64+1.91 (+1.21%)
At close: 04:00PM EST
159.64 0.00 (0.00%)
After hours: 05:32PM EST
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Engulfing Line (Bearish)

Engulfing Line (Bearish)

Previous Close157.73
Open157.45
Bid159.45 x 800
Ask162.89 x 900
Day's Range156.39 - 159.74
52 Week Range132.24 - 243.52
Volume677,223
Avg. Volume1,591,590
Market Cap23.482B
Beta (5Y Monthly)0.52
PE Ratio (TTM)25.96
EPS (TTM)6.15
Earnings DateJan 24, 2024 - Jan 29, 2024
Forward Dividend & Yield1.92 (1.20%)
Ex-Dividend DateNov 08, 2023
1y Target Est178.38
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued
-4% Est. Return

Subscribe to Yahoo Finance Plus to view Fair Value for RMD

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • ResMed Inc.
    RMD: Raising target price to $125.00RESMED INC has an Investment Rating of SELL; a target price of $125.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Low; a Growth Subrating of Low; and a Value Subrating of Medium.
    Rating
    Fair Value
    Economic Moat
    4 days agoArgus Research
View more